STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice

In recent years, there has been an increasing interest in immunomodulatory therapy as a means to treat various conditions, including infectious diseases. For instance, Toll-like receptor (TLR) agonists have been evaluated for treatment of genital herpes. However, although the TLR7 agonist imiquimod...

Descripción completa

Detalles Bibliográficos
Autores principales: Skouboe, Morten K., Knudsen, Alice, Reinert, Line S., Boularan, Cedric, Lioux, Thierry, Perouzel, Eric, Thomsen, Martin K., Paludan, Søren R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897032/
https://www.ncbi.nlm.nih.gov/pubmed/29608601
http://dx.doi.org/10.1371/journal.ppat.1006976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897032/
https://www.ncbi.nlm.nih.gov/pubmed/29608601
http://dx.doi.org/10.1371/journal.ppat.1006976

Ejemplares similares